Skip to content

Public FDA record

Z-1236-2009: Cerner Bridge Medical Transfusion Administration and Specimen Collections, Versions 3.4.0, 3.4.1 and 3.4.

Recall record Z-1236-2009 for Cerner Corp. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1236-2009
Company in FDA record
Cerner Corp
FDA classification date
May 1, 2009
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Specimen labels printing incorrect patient demographics.

Source facts

Action
Cerner Corporation issued a "Priority Review Flash" dated January 15, 2009 via e-mail to consignees using the software. The letter described the violative nature of the software and explained the proper navigation controls needed to prevent further issues. Further questions should be addressed to Bridge Client Support at 1-800-786-0239.
Initiated
2009-01-19
Root cause
Software design
Terminated
2012-03-22
Distribution
Nationwide distribution to states of OH, NC, MO and MI.
Recall number
Z-1236-2009
Recall status
Terminated
CDRH record ID
79872
FDA classified
2009-05-01
Recall event number
51319

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗